ArticleInternational journal of clinical oncology2024

Clinical impact of concomitant BIO-three use in advanced or recurrent non-small cell lung cancer treated with immune-checkpoint inhibitor.

Hitomi Nakatsukasa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.